* Encompass Health Corp reported quarterly adjusted earnings of $1.03​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of 86 cents. The mean expectation of thirteen analysts for the quarter was for earnings of 94 cents per share. Wall Street expected results to range from 89 cents to $1.01 per share.

* Revenue rose 11.9% to $1.35 billion from a year ago; analysts expected $1.33 billion.

* Encompass Health Corp's reported EPS for the quarter was $1.06​.

* The company reported quarterly net income of $108.2 million.

* Encompass Health Corp shares had fallen by 3.3% this quarter and gained 40.1% so far this year.

FORECAST CHANGES

* The mean earnings estimate of analysts had fallen by about 1.3% in the last three months.​

* In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

* The average consensus recommendation for the healthcare facilities & services peer group is also "buy"

Wall Street's median 12-month price target for Encompass Health Corp is $108.00 This summary was machine generated from LSEG data October 29 at 02:40 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,

MISSED

Sep. 30 2024 0.94 1.03 Beat

Jun. 30 2024 1.01 1.11 Beat

Mar. 31 2024 0.94 1.12 Beat

Dec. 31 2023 0.82 0.95 Beat